Credit Suisse Hais tias AbbVie's Humira Patent Cliff tuaj yeem muab lub zog los txhawb kev loj hlob

  • credit Suisse tau pib kev pab them nqi rau AB Ab Inc (NYSE: ABBV) nrog kev ntsuas qhov ua tau zoo thiab a nqe phiaj nqi ntawm $ 170.

  • AbbVie sawv ntawm qhov muag zoo tshaj plaws Humira US poob ntawm kev tsis suav nrog (LOE) hauv 2023. Thaum qhov no tseem yog qhov tseem ceeb ntawm kev sib tham ntawm cov tub ua lag luam, Credit Suisse pom nws yog ib qho kev txhawb nqa los thawb cov lus piav qhia los ntawm zaj dab neeg muaj nqis mus rau zaj dab neeg loj hlob.

  • Raws li cov kws tshuaj ntsuam xyuas Credit Suisse, kev tswj hwm tau muab lub tsev thaiv kev loj hlob nrog Skyrizi, Rinvoq, thiab kev zoo nkauj, uas tsis txaus siab.

  • Related: AbbVie Tshaj Tawm Cov Nyiaj Tau Los sib xyaw, Tightens Kev taw qhia, Lifts Peb Lub Hlis Dividend.

  • Tsis zoo li feem ntau cov phooj ywg, yuav muaj kev txwv ceev rau kev txhim kho kev lag luam (BD), vim tias tsis muaj lwm cov ntsiab lus LOEs mus txog rau 2029. Muab nws cov nyiaj tau los muaj zog thiab cov nyiaj tau los siab, qhov kev ntsuas qis yog qhov txaus nyiam nkag mus rau kev tswj hwm kev rov qab mus rau kev loj hlob. hauv 2024.

  • Nqe Nqis: ABBV shares tau nce 1.80% ntawm $ 154.895 ntawm daim tshev kawg rau hnub Friday.

  • Duab Ntawm Tuam Txhab

Tseeb Ratings for ABBV

Hnub

Tshaj tawm

Action

Los ntawm

Yuav

Feb 2022

UBS

Downgrades

yuav

nruab nrab

Feb 2022

Mizuho

Txij nkawm

yuav

Feb 2022

Barclays

Txij nkawm

Sib npaug - Qhov hnyav

Saib Ntau Cov Kev Ntsuas Ntsuas rau ABBV

Saib Qhov Ntsuam Kev Ntsuam Xyuas Cov Ntaus Tawm Tshiab

Saib ntxiv ntawm Benzinga

Tsis txhob nco lub sijhawm ceeb toom ntawm koj cov khoom lag luam - koom Lub Npe Lub Npe Pro dawb! Sim cov cuab yeej uas yuav pab koj nqis peev smarter, sai dua, thiab zoo dua.

© 2022 Benzinga.com. Benzinga tsis muab lus qhia txog peev. Qoob loo.

Tau qhov twg los: https://finance.yahoo.com/news/credit-suisse-says-abbvies-humira-193114116.html